Neil A. Goldenberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Neil A. Goldenberg has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Marilyn J. Manco-Johnson
4 shared publications- Brian Re Branchford
Division of Hematology, Department of Pediatrics, Medical College of Wisconsin, Wauwatosa, WI
2 shared publications S. R. Kahn
Center for Clinical Epidemiology and Community Studies, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC, Canada
2 shared publications- Anjali Sharathkumar
Stead Family Department of Pediatrics, The University of Iowa, Iowa City, IA
1 shared publication - Anthony Kam Chuen Chan
McMaster University, Hamilton, Canada
1 shared publication C. A. Leissinger
Section of Hematology and Medical Oncology, Department of Medicine, The Louisiana Center for Bleeding and Clotting Disorders, Tulane University, New Orleans, LA
1 shared publication
Latest Publications
- 1 May 2012
- Published by Elsevier in Thrombosis Research
- Vol. 129 (5) , 662-663
Sensitivity of discharge diagnosis ICD-9 codes for pediatric venous thromboembolism is greater than specificity, but still suboptimal for surveillance and clinical research
- 1 May 2012
- Published by Elsevier in Thrombosis Research
- Vol. 129 (5) , 662-663
Sensitivity of discharge diagnosis ICD-9 codes for pediatric venous thromboembolism is greater than specificity, but still suboptimal for surveillance and clinical research
- 15 December 2011
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 10 (3) , 477-480
Definition of post‐thrombotic syndrome following lower extremity deep venous thrombosis and standardization of outcome measurement in pediatric clinical investigations
- 15 December 2011
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 10 (3) , 477-480
Definition of post‐thrombotic syndrome following lower extremity deep venous thrombosis and standardization of outcome measurement in pediatric clinical investigations
- 7 September 2011
- Published by Wiley in Haemophilia
- Vol. 18 (3) , 326-331
Outcomes of mentored, grant‐funded fellowship training in haemostasis /thrombosis: findings from a nested case–control survey study
Summary. Successful strategies by which to effectively recruit and retain academic subspecialists in benign haematology have not been established. To evaluate the effectiveness of a grant‐funded, mentored fellowship with respect to retention and early career goals in haemostasis/thrombosis, we sought to compare outcomes for graduates of a grant‐funded, mentored fellowship training programme in haemostasis/thrombosis [the National Hemophilia Foundation (NHF)‐Baxter Clinical Fellowship Award] during conventional haematology/oncology fellowship training (cases), vs. their training peers who were graduates of conventional haematology/oncology fellowship training alone (controls), via a nested case‐control survey study. Survey response rate was 85% (11/13) for cases and 90% (9/10) for controls. All respondents had pursued careers in academic haematology/oncology. Median (range) percent time spent in benign haematology postfellowship was 98% (70–100%) for cases vs. 0% (0–20%) for controls. Time spent in research was significantly greater among cases than controls (median 80% [range: 42–90%] vs. 55% [10–80%], respectively; P = 0.01). By years 3–4 postfellowship, median annual number of peer‐reviewed publications was higher for cases than controls (3.5 vs. 1.0; P = 0.01). Cases were also more successful in grant funding (including K‐awards). These data suggest that a grant‐funded, mentored fellowship training programme in haemostasis/thrombosis may be superior to conventional haematology/oncology fellowship training alone with respect to outcomes of retention in clinical care/research, early‐career grant funding and publication productivity.
- 7 September 2011
- Published by Wiley in Haemophilia
- Vol. 18 (3) , 326-331
Outcomes of mentored, grant‐funded fellowship training in haemostasis /thrombosis: findings from a nested case–control survey study
Summary. Successful strategies by which to effectively recruit and retain academic subspecialists in benign haematology have not been established. To evaluate the effectiveness of a grant‐funded, mentored fellowship with respect to retention and early career goals in haemostasis/thrombosis, we sought to compare outcomes for graduates of a grant‐funded, mentored fellowship training programme in haemostasis/thrombosis [the National Hemophilia Foundation (NHF)‐Baxter Clinical Fellowship Award] during conventional haematology/oncology fellowship training (cases), vs. their training peers who were graduates of conventional haematology/oncology fellowship training alone (controls), via a nested case‐control survey study. Survey response rate was 85% (11/13) for cases and 90% (9/10) for controls. All respondents had pursued careers in academic haematology/oncology. Median (range) percent time spent in benign haematology postfellowship was 98% (70–100%) for cases vs. 0% (0–20%) for controls. Time spent in research was significantly greater among cases than controls (median 80% [range: 42–90%] vs. 55% [10–80%], respectively; P = 0.01). By years 3–4 postfellowship, median annual number of peer‐reviewed publications was higher for cases than controls (3.5 vs. 1.0; P = 0.01). Cases were also more successful in grant funding (including K‐awards). These data suggest that a grant‐funded, mentored fellowship training programme in haemostasis/thrombosis may be superior to conventional haematology/oncology fellowship training alone with respect to outcomes of retention in clinical care/research, early‐career grant funding and publication productivity.
- 1 February 2011
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 22 (2) , 121-132
Percutaneous Mechanical and Pharmacomechanical Thrombolysis for Occlusive Deep Vein Thrombosis of the Proximal Limb in Adolescent Subjects: Findings from an Institution-based Prospective Inception Cohort Study of Pediatric Venous Thromboembolism
- 1 February 2011
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 22 (2) , 121-132
Percutaneous Mechanical and Pharmacomechanical Thrombolysis for Occlusive Deep Vein Thrombosis of the Proximal Limb in Adolescent Subjects: Findings from an Institution-based Prospective Inception Cohort Study of Pediatric Venous Thromboembolism
- 1 November 2010
- Published by Elsevier in The Journal of Pediatrics
- Vol. 157 (5) , 852-855
Validation of Upper Extremity Post-Thrombotic Syndrome Outcome Measurement in Children
- 1 November 2010
- Published by Elsevier in The Journal of Pediatrics
- Vol. 157 (5) , 852-855
Validation of Upper Extremity Post-Thrombotic Syndrome Outcome Measurement in Children
- 30 June 2010
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 95 (11) , 1952-1959
Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors
Post-thrombotic syndrome is a manifestation of chronic venous insufficiency following deep venous thrombosis. This systematic review was conducted to critically evaluate pediatric evidence on frequency of occurrence, validity of outcome measures, and prognostic indicators of post-thrombotic syndrome. A comprehensive literature search of original reports revealed 19 eligible studies, totaling 977 patients with upper/lower extremity deep venous thrombosis. Calculated weighted mean frequency of post-thrombotic syndrome was 26% (95% confidence interval: 23-28%) overall, and differed significantly by prospective/non-prospective analysis and use/non-use of a standardized outcome measure. Standardized post-thrombotic syndrome outcome measures included an adaptation of the Villalta scale, the Clinical-Etiologic-Anatomic-Pathologic classification, and the Manco-Johnson instrument. Data on validity were reported only for the Manco-Johnson instrument. No publications on post-thrombotic syndrome-related quality of life outcomes were identified. Candidate prognostic factors for post-thrombotic syndrome in prospective studies included use/non-use of thrombolysis and plasma levels of factor VIII activity and D-dimer. Given that affected children must endure chronic sequelae for many decades, it is imperative that future collaborative pediatric prospective cohort studies and trials assess as key objectives and outcomes the incidence, severity, prognostic indicators, and health impact of post-thrombotic syndrome, using validated measures.
- 30 June 2010
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 95 (11) , 1952-1959
Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors
Post-thrombotic syndrome is a manifestation of chronic venous insufficiency following deep venous thrombosis. This systematic review was conducted to critically evaluate pediatric evidence on frequency of occurrence, validity of outcome measures, and prognostic indicators of post-thrombotic syndrome. A comprehensive literature search of original reports revealed 19 eligible studies, totaling 977 patients with upper/lower extremity deep venous thrombosis. Calculated weighted mean frequency of post-thrombotic syndrome was 26% (95% confidence interval: 23-28%) overall, and differed significantly by prospective/non-prospective analysis and use/non-use of a standardized outcome measure. Standardized post-thrombotic syndrome outcome measures included an adaptation of the Villalta scale, the Clinical-Etiologic-Anatomic-Pathologic classification, and the Manco-Johnson instrument. Data on validity were reported only for the Manco-Johnson instrument. No publications on post-thrombotic syndrome-related quality of life outcomes were identified. Candidate prognostic factors for post-thrombotic syndrome in prospective studies included use/non-use of thrombolysis and plasma levels of factor VIII activity and D-dimer. Given that affected children must endure chronic sequelae for many decades, it is imperative that future collaborative pediatric prospective cohort studies and trials assess as key objectives and outcomes the incidence, severity, prognostic indicators, and health impact of post-thrombotic syndrome, using validated measures.
- 1 January 2010
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 31 (1) , 131-133
The “parallel-cohort RCT”: Novel design aspects and application in the Kids-DOTT trial of pediatric venous thromboembolism
- 1 January 2010
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 31 (1) , 131-133
The “parallel-cohort RCT”: Novel design aspects and application in the Kids-DOTT trial of pediatric venous thromboembolism